Results 121 to 130 of about 648,180 (293)

Assessing the Impact of Standardized Patient Encounters on Students' Medical History-taking Skills in Practice. [PDF]

Am J Pharm Educ, 2023
Zerilli T, Fidler BD, Tendhar C.
europepmc   +1 more source

Metastasis on pause: How dormant tumor cells stay hidden within the tumor microenvironment and evade immune surveillance

Molecular Oncology, EarlyView.
Dormant cancer cells can hide in distant organs for years, evading treatment and the immune system. This review highlights how signals from the surrounding tissue and immune environment keep these cells inactive or trigger their reawakening. Understanding these mechanisms may help develop therapies to eliminate or control dormant cells and prevent ...
Kanishka Tiwary, Jose Javier Bravo‐Cordero   +1 more
wiley   +1 more source

Use of body-mapping (an art therapy methodology) to enhance medical student history taking skills and the students’ response [PDF]

Medical school educators are tasked with the responsibility of teaching medical students how to take relevant medical histories from patients and develop communication and interpersonal skills.
Berman, Hayley, Spencer, Neil, Schamroth, Alan   +2 more
core   +1 more source

Evaluating an app for digital medical history taking in urgent care practices: study protocol of the cluster-randomized interventional trial 'DASI'. [PDF]

BMC Prim Care, 2023
Noack EM, Zajontz D, Friede T, Antweiler K, Hummers E, Schmidt T, Roddewig L, Schröder D, Müller F.   +8 more
europepmc   +1 more source

Circulating tumor cell viability during and after radiotherapy mirrors treatment response in cancer patients

Molecular Oncology, EarlyView.
Radiotherapy (RT) response depends on the DNA repair capacity of tumor and host cells. We show that circulating tumor cell (CTC) counts and apoptosis rates before and after RT predict treatment response and outcome, which can be accessed via easily accessible liquid biopsy approaches. Created in BioRender. Wikman, H.
Yvonne Goy, Jana Löptien, Cornelia Coith, Afroditi Nanou, Katharina Hintelmann, Pinnschmidt Hans, Cordula Petersen, Klaus Pantel, Sabine Riethdorf, Kerstin Borgmann, Harriet Wikman   +10 more
wiley   +1 more source

Patients' Attitude towards Medical Students in a Teaching Hospital of Pakistan

Journal of Islamic International Medical College, 2014
Objective: To study patient’s attitude towards medical students on clinical clerkship rotation in a hospital Study Design: Descriptive Cross Sectional Study.
Muhammad Nadim Akbar Khan, Noor Mah Khan, Saadia Sultana
doaj  

Carney complex- why thorough medical history taking is so important - report of three cases and review of the literature. [PDF]

Endocrine, 2023
Harbeck B, Flitsch J, Kreitschmann-Andermahr I.   +2 more
europepmc   +1 more source

Developmental programmes drive cellular plasticity, disease progression and therapy resistance in lung adenocarcinoma

Molecular Oncology, EarlyView.
This study shows that lung adenocarcinomas exploit developmental branching morphogenesis to acquire a therapy resistant basal‐like tumour cell state. This process was found to be regulated by combined TP53 loss‐of‐function and type‐I interferon signalling, identifying a novel axis for biomarker and therapeutic target discovery.
Kamila J Bienkowska, Stephany Gallardo, Nur S. Zainal, Leena Arora, Matthew Ellis, Maria‐Antoinette Lopez, Judith Austine, Sai Pittla, Serena J Chee, Aiman Alzetani, Emily C Shaw, Christian H Ottensmeier, Gareth J Thomas, Christopher J Hanley   +13 more
wiley   +1 more source

Online medical history taking course: Opportunities and limitations in comparison to traditional bedside teaching. [PDF]

GMS J Med Educ, 2022
Lange S, Krüger N, Warm M, Op den Winkel M, Buechel J, Huber J, Genzel-Boroviczény O, Fischer MR, Dimitriadis K.   +8 more
europepmc   +1 more source

Stimulator of interferon genes agonist augmented antitumor immunity of osimertinib in Egfr‐mutated lung cancer

Molecular Oncology, EarlyView.
Combining osimertinib with the STING agonist ADU‐S100 activates innate and adaptive immunity to overcome the non‐inflamed microenvironment of Egfr‐mutant lung cancer. This combination increases NK and CD8+ T‐cell infiltration, associated with activation of the STING‐IRF3 pathway and local immunogenic cell death.
Jun Nishimura, Tadahiro Kuribayashi, Johannes Brägelmann, Sachi Okawa, Masataka Taoka, Shunta Mori, Tomoka Nishimura, Takaaki Tanaka, Go Makimoto, Kiichiro Ninomiya, Kammei Rai, Eiki Ichihara, Ryohei Katayama, Katsuyuki Hotta, Masahiro Tabata, Yosuke Togashi, Yoshinobu Maeda, Martin L. Sos, Katsuyuki Kiura, Kadoaki Ohashi   +19 more
wiley   +1 more source